Hematology and Oncology

EmailEmail    |   Bookmark Page Bookmark  |   RSS Feeds RSS  |   Print Page Print  

Kenneth Friedman, M.D.

Associate Professor of Medicine

 

 

 

 

Kenneth Friedman, M.D., is Associate Professor of Medicine at the Medical College of Wisconsin, Division of Hematology and Oncology and Medical Director of the Hemostasis Reference Laboratory of the BloodCenter of Wisconsin. He specializes in the care of patients with abnormalities of blood clotting. He graduated from the State University of New York Upstate Medical Center in 1980, completed an internal medicine residency at Temple University Hospital in Philadelphia and a fellowship in hematology/oncology at the Columbia Presbyterian Medical Center in New York City. After completing a fellowship at the BloodCenter of Wisconsin in Transfusion Medicine, Dr. Friedman became a faculty member at the University of New Mexico and then returned to Milwaukee to join the physician staff at BloodCenter of Wisconsin. He is board certified in Internal Medicine, Medical Oncology, Hematology, and Transfusion Medicine. He has numerous publications and his current research interests are related to the laboratory evaluation and treatment of patients with diseases that interfere with the regulation of blood clotting.

Selected Publications:
1. Lankiewicz MW, Hays J, Friedman KD, Tinkoff G, Blatt PM: Urgent reversal of warfarin with prothrombin complex concentrate. J Thrombosis Haemostasis 2006;4:967-970.
2. Slayton WB, Patel M, Sola-Visner M, Harris N, Rivers A, Montgomery RR, Friedman KD: Type 2B von Willebrand disease associated with the release of platelet aggregates in the bone marrow. J Pediatr Hematol Oncol 2008; 30:708-11
3. Scott E, Puca K, Heraly J, Gottschall J, Friedman K: Evaluation and comparison of coagulation factor activity in fresh-frozen plasma and 24-hour plasma at thaw and after 120 hours of 1 to 6 °C storage. Transfusion 2009; 49: 1584-1491
4. Flood VH, Friedman KD, Gill JC, Morateck PA, Wren JS, Scott JP, Montgomery RR. Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function. J Thromb Haemost 2009:7:1832-1839
5. Flood VH, Gill JC, Moratek PA, Christopherson PA, Friedman KD, Haberrichter SL, Branchford BR, Hoffmann RG, Abshire TC, Di Paola JA, Hoots WK, Leissinger C, Lusher JM, Ragni MV, Shapiro AD, Montgomery RR. Common VWF exon 28 polymorphisms in African Americans affects the VWF activity assay by ristocetin cofactor. Blood 2010; 116:280-286.

 

Best Doctors® and the star-in-cross logo are registered trademarks of Best Doctors, Inc. in the United States and other countries.
 
webmaster@mcw.edu
© 2014 Medical College of Wisconsin
Page Updated 02/11/2014